issues with semaglutide GLP-1 drugs such as and tirzepatide are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights Common And Rare Side Effects

The disease is also believed to have affected other ethnic groups, but was misdiagnosed due to the doctors' ignorance (236, 237)

An important note: In August 2025, the Trump Administration said it is considering a pilot program that would cover weight-loss drugs under Medicare for five years

Metabolic resistance or medication adjustments (changing to another type of GLP1/GIP, such as tirzepatide) may be needed, so seek medical advice

They may be prescribed for individuals who meet certain criteria

A: Avoid vigorous massage, as this can worsen bruising

Susana Monereo , Jefa del Servicio de Endocrinologa y Nutricin del Hospital Ruber Internacional, recientemente ofreci una actualizacin sobre la obesidad en la sesin general de nuestro hospital